Tivic Health Systems (NASDAQ:TIVC) Trading Down 0.5% – Time to Sell?

Tivic Health Systems, Inc. (NASDAQ:TIVCGet Free Report) shares were down 0.5% during mid-day trading on Monday . The company traded as low as $0.7217 and last traded at $0.8457. Approximately 2,033,377 shares changed hands during mid-day trading, an increase of 4,844% from the average daily volume of 41,131 shares. The stock had previously closed at $0.8503.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tivic Health Systems in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

Read Our Latest Stock Analysis on Tivic Health Systems

Tivic Health Systems Trading Down 6.9%

The company has a fifty day simple moving average of $1.05 and a 200-day simple moving average of $1.99.

Institutional Investors Weigh In On Tivic Health Systems

An institutional investor recently bought a new position in Tivic Health Systems stock. Marex Group plc purchased a new position in Tivic Health Systems, Inc. (NASDAQ:TIVCFree Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 39,283 shares of the company’s stock, valued at approximately $163,000. Marex Group plc owned 3.64% of Tivic Health Systems at the end of the most recent reporting period. 4.25% of the stock is owned by institutional investors.

About Tivic Health Systems

(Get Free Report)

Tivic Health Systems is a commercial-stage medical technology company that develops and markets non-drug, neuromodulation-based therapies for nasal and sinus health. The company’s solutions are designed to alleviate sinus pain, pressure and congestion through gentle microcurrent and vibration stimulation. By targeting the underlying nerve pathways in the nasal passages, Tivic Health aims to provide an alternative to over-the-counter and prescription medications without introducing systemic side effects.

The flagship product, ClearUP™ Sinus Pain Relief, is an FDA-cleared, hand-held device intended for home use.

Read More

Receive News & Ratings for Tivic Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivic Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.